Global Enteral Nutrition Market, by Disease Type (Standard and Chronic), by Age Group (Below 15, 15 to 30, 30 to 45, 45 to 60, and Above 60), by End-use Industry (Hospitals, Clinics, and Long Term Care Facilities), by and Geography - Trends, and Forecast to 2025

  • Published On : Dec 2017 |
  • Pages : 325 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Enteral Nutrition Market - Insights

Enteral nutrition, also known as tube feeding refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including normal oral diet or liquid supplements. Nasoenteral, also known as nasogastric feeding tube is placed in the stomach through the nose, whereas a jejunostomy tube is placed directly through the skin. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and strokes. Moreover, the formula helps premature infants to gain required nutrition and medications. According to the National Center for Biotechnology Information (NCBI), nasogastric tube is most preferred method for short term feeding in the acute phase of stroke and is commonly used for providing nutrition, hydration, and essential medications.

Major factors propelling growth of the global enteral nutrition market are rising prevalence of chronic diseases such as diabetes, heart disease, and cancer coupled with increasing health care expenditure, worldwide. According to the American Diabetes Association (ADA), long term use of nutritional support with diabetes specific formula helps reducing chronic complications of diabetes such as cardiovascular diseases and according to the National Center for Biotechnology Information (NCBI), the use of enteral nutrition is helpful in patients with chronic heart failure (CHF). Further, according to the Office for National Statistics, in the U.K., total health care expenditure was US$ 239.92 billion in 2014, which increased by 3.6% and pegged at US$ 248.51 billion in 2015. High health care expenditure of a region depicts the affordability of the patients for expensive medical services. This in turn, is anticipated to support the overall growth of enteral nutrition market as according to NCBI, tube feeding a patient involves higher cost as compared to those without tubes. Enteral nutrition is used for patients across all age groups, however, the geriatric population segment is the most lucrative segment. Health concerns such as metabolic disorders and loss of appetite are more prevalent among the geriatric population, which is a key factor for growth of the enteral nutrition market.

Complications associated with enteral nutrition, include patient safety risks and feeding and medication errors, which is a restraining factor for this market growth. For instance, according to NCBI, placing of a nasogastric tube is associated with various risks including gastrointestinal complications, aspiration, mechanical complications, and metabolic complications.

North America dominated the enteral nutrition market in 2016, accounting for over 30% of the market share and is expected to retain its dominance throughout the forecast period (2017–2025). Rising geriatric population in the region coupled with increasing incidences of chronic illnesses are some of the key factors complementing growth of the enteral nutrition market in the region. According to the Centers for Disease Control and Prevention (CDC), heart diseases, cancer, diabetes and strokes were the leading causes of disabilities and deaths in the U.S., in 2016. Moreover, according to the National Cancer Institute, in 2016, approximately 1.6 million patients were diagnosed with cancer in the U.S., out of which 0.59 million died from the disease. These factors are responsible for increased use of enteral nutrition in the U.S., thereby fuelling growth of the market in North America.

Asia Pacific is projected to be the fastest growing market for enteral nutrition, exhibiting a CAGR of 6.35% over the forecast period, with India and China being the major contributors in the region. China and India have high proportion of geriatric population. According to the United Nations Economic and Social Commission for Asia and Pacific (UNESCAP), the geriatric population in Asia Pacific is rising significantly. In 2016, the proportion of geriatric population in North East Asia was around 17%, which is anticipated to cross 35%, whereas, in North and Central Asia it is projected to cross 20% by 2050. Furthermore, diabetes has become a major concern for the populace in this region.

According to the data provided by the National Center for Biotechnology Information (NCBI), in 2014, the region accounted for approximately 150 million diabetic patients, out of which, over 95% fall in the category of type 2 diabetes (T2DM). Further, according to the World Health Organization (WHO), in 2016, China had high diabetic population, which was around 110 million and the number is expected to increase to 150 million by 2040. However, China’s healthcare spending has increased significantly over the past decade, from US$ 90.8 billion in 2004 to US$ 590.2 billion in 2014 and the same is expected to increase further in the future. The steadily growing health care expenditure is expected to confer a boost to this market growth as high expenditure on health care indicates the affordability of patients for expensive medical services. This in turn, is expected to strongly support growth of the enteral nutrition market in Asia Pacific in the near future.

Among disease type, chronic segment accounted for the largest share in 2016 and is expected to retain its dominance throughout the forecast period. Rising cases of chronic diseases such as cancer, cardiovascular diseases, and diabetes worldwide is propelling demand for this nutrition. According to the World Health Organization (WHO), in 2015, out of 56.4 million global deaths, around 70% were due to non-communicable diseases (NCDs), which include cardiovascular diseases, diabetes, cancer, and chronic lung diseases.

Figure1. Global Enteral Nutrition Market Share, by Age Group, 2016 (%)

enteral nutrition market

Source: Coherent Market Insights (2017)

Among age groups, the above 60 segment accounted for the largest market share in 2016, and is expected to be the fastest growing segment, as geriatric population requires more support services and the healthcare spending is also high for this segment. According to the Department of Economic and Social Affairs Population Division, the geriatric population (aging 60 or above) is expected to increase by 56% between 2015 and 2030 and according to the NCBI spending on health care services for the elderly population has been increasing since 1965. These are the major factors, which are expected to support growth of the enteral nutrition market over the forecast period.

Major players operating in the global enteral nutrition market include Nestle S.A., Baxter International Inc., B. Braun Holding GmbH & Co. KG, Abbott Laboratories, Groupe Danone, Reckitt Benckiser Group Plc, Perrigo Company Plc., Meiji Seika Pharma Co. Ltd., and Fresenius Kabi AG.

Enteral nutrition refers to delivery of food containing carbohydrates, proteins, water, fat, minerals, and vitamins in the body using gastrointestinal tract with the help of feeding tubes. It is imperative for patients having functional gastrointestinal tract however are, unable to maintain a safe or adequate oral intake. Further, a tube placed in nose, is known as nasoenteral tube, where it passes through the nasal cavity and into the stomach. However, when a tube passes through the skin into the stomach it is called gastrostomy. Such tubes aid patients to ingest food, who are unable to consume normally.

Market Dynamics

Rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and neurological diseases are some of the major factors complementing growth of this market. According to the National Center for Biotechnology Information (NCBI), the prevalence of chronic disease has increased from 34.9% to 41.8% during 2004-2011. Rising number of preterm births and increasing geriatric population across the global are some of the key factors supporting growth of this market. According to the National Institutes of Health (NIH), the world’s older population is steadily growing and 8.5% of people worldwide (approximately 617 million) were recorded aging 65 and older in 2016.

North America held a dominant position in the global enteral nutrition market in 2016, owing to increasing cases of preterm births and high prevalence of chronic diseases in the region. According to the National Center for Biotechnology Information (NCBI), cases of preterm births was fairly high both in the U.S. and Canada, in 2016 and according to the Centers for Disease Control and Prevention (CDC), 382786, number of preterm births were recorded in U.S. by March 2017. High healthcare spending among the populace in North America is linked with the affordability of the patients for expensive medical services. This in turn, is expected to support the growth of the enteral nutrition market in this region.

Asia Pacific is projected to be the fastest growing region for enteral nutrition over the forecast period owing to increasing number of patients suffering from disease-associated malnutrition (DAM). Further, rising geriatric population in the region is expected to support growth of the enteral nutrition market in the future. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), in East and North Asian countries such as Japan and the Republic of Korea, over a third of the population is expected to be 60 years or older by 2050.

Key features of the study:

  • This report provides in-depth analysis of the enteral nutrition market, market size (US$ Billion), and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025)
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global enteral nutrition market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
  • The global enteral nutrition market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision-making through the various strategy matrices used in analyzing the enteral nutrition market

Detailed Segmentation:

  • Global Enteral Nutrition Market, By Disease Type:
    • Standard
      • Polymeric
      • Monomeric
    • Chronic
      • Renal
      • Hepatic
      • Diabetic
      • Others
  • Global Enteral Nutrition Market, By Age Group:
    • Below 15
    • 15 to 30
    • 30 to 45
    • 45 to 60
    • Above 60
  • Global Enteral Nutrition Market, By End-use Industry:
    • Hospitals
    • Clinics
    • Long Term Care Facilities
      • Home Care
      • Hospices
  • Global Enteral Nutrition Market, By Geography:
    • North America
      • U.S.
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Canada
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
    • Europe
      • U.K.
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Germany
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Italy
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • France
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Spain
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Russia
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Rest of Europe
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
    • Asia Pacific
      • China
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • India
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Japan
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • ASEAN
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Australia
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • South Korea
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Rest of Asia Pacific
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
    • Latin America
      • Brazil
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Mexico
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Argentina
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Rest of Latin America
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
    • Africa
      • Northern Africa
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Central Africa
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • South Africa
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
    • Middle East
      • GCC
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Israel
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
      • Rest of Middle East
        • By Disease Type:
          • Standard
            • Polymeric
            • Monomeric
          • Chronic
            • Renal
            • Hepatic
            • Diabetic
            • Others
        • By Age group:
          • Below 15
          • 15 to 30
          • 30 to 45
          • 45 to 60
          • Above 60
        • By End-use Industry:
          • Hospitals
          • Clinics
          • Long Term Care Facilities
            • Home Care
            • Hospices
  • Company Profiles
    • Nestle S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Baxter International Inc.
    • B. Braun Holding GmbH & Co. KG
    • Abbott Laboratories
    • Groupe Danone
    • Reckitt Benckiser Group Plc
    • Perrigo Company Plc.
    • Meiji Seika Pharma Co. Ltd.
    • Fresenius Kabi AG

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Disease Type
      • Market Snippet By Age Group
      • Market Snippet By End-Use Industry
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Regulatory Scenario
      • Industry Trend
      • Merger and Acquisitions
      • New Product Approvals/Launch
      • Promotion and Marketing Initiatives
    • Cost Tier Down Analysis
  4. Global Enteral Nutrition Market, By Disease Type, 2016- 2025 (USD Billion)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2016 - 2025
      • Segment Trends
    • Standard
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
        • Polymeric
        • Monomeric
    • Chronic
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
        • Renal
        • Hepatic
        • Diabetic
        • Others
  5. Global Enteral Nutrition Market, By Age Group, 2016 - 2025 (USD Billion)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2016 - 2025
      • Segment Trends
    • Below 15
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
    • 15 to 30
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
    • 30 to 45
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
    • 45 to 60
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
    • Above 60
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
  6. Global Enteral Nutrition Market, By End-Use Industry, 2016- 2025 (USD Billion)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2016 - 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
    • Long Term Care Facilities
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2025, (USD Billion)
        • Home Care
        • Hospices
  7. Global Enteral Nutrition Market, By Region, 2016 - 2025 (USD Billion)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, For Regions, 2016 - 2025
    • North America
      • Market Share Analysis, By Country, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2016 - 2025
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
    • Europe
      • Market Share Analysis, By Country, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2016 - 2025
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • France
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Spain
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
    • Asia Pacific
      • Market Share Analysis, By Country, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2016 - 2025
        • China
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • India
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
    • Latin America
      • Market Share Analysis, By Country, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2016 - 2025
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Argentina
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
    • Africa
      • Market Share Analysis, By Country, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2016 - 2025
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
    • Middle East
      • Market Share Analysis, By Country, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2016 - 2025
        • GCC
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Disease Type, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By Age Group, 2016 - 2025 (USD Billion)
          • Market Size and Forecast, By End-use Industry, 2016 - 2025 (USD Billion)
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Nestle S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • B. Braun Holding GmbH & Co. KG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Groupe Danone
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Reckitt Benckiser Group Plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Perrigo Company Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Meiji Seika Pharma Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Fresenius Kabi AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

* Browse 80 market data tables* and 40 figures* on "Enteral Nutrition Market” - Global forecast to 2025.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.